GOLDEN, Colo.--(BUSINESS WIRE)--Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma, announced that it has entered into a contract with Mokshagundam Biotechnologies, a private research organization established to develop alternative meat sources, to develop cell culture medium for use in exploration of alternative food sources derived from stem cells. Cell culture media is a complex solution of salts and nutrients designed to support growth of living cells; each type of cell requires specific components within the media to optimize its growth. This project intends to utilize cultured marine invertebrates, nourished by medium only as a source of food for fish initially and possibly domestic animals. The initial target organism has a well-defined stem cell system that results in regeneration of body parts following amputation, and continuous growth of the organism. Vitro is to provide prototype media to support expansion of these marine organisms without requiring additional food sources. Successful development of such a product could lead to commercial production of food sources that rely on cell culture technology utilizing cell culture medium as the primary consumable product in the manufacturing process. This technology may also be expanded to include animal and human food sources using stem cells that give rise to muscle cells, which is the primary ingredient of meat. The manufacture of stem cell-derived meat allows complete control of the meat with regard to chemical content and the elimination of contaminants such as E. coli, hormones, antibiotics, pesticides and the cause of “Mad Cow Disease.” Additional substances may be added to enhance taste and nutritional value.
